Aluminum chelation: Chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine

References

• Aarseth , H. P. and Ganss , R. 1990 . Removal of chelated aluminium during haemodialysis using polysulphone high‐flux dialysers . Nephrol. Dial. Transplant , 5 : 942 – 944 .
   PubMedGoogle Scholar
• Abreo , K. , Brown , S. T. , Sella , M. and Trapp , G. 1989 . Application of an erythrocyte aluminum assay in the diagnosis of aluminum‐associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy . J. Lab. Clin. Med. , 113 : 50 – 57 .
   PubMed Web of Science ®Google Scholar
• Ackrill , P. and Day , J. P. 1993 . The use of desferrioximine in dialysis‐associated aluminium disease . Cont. Nephrol. , 102 : 125 – 134 .
   PubMedGoogle Scholar
• Ackrill , P. , Ralston , A. J. , Day , J. P. and Hodge , K. C. 1980 . Successful removal of aluminium from patients with dialysis encephalopathy . Lancet , ii : 692 – 693 .
   Google Scholar
• Ackrill , P. , Day , J. P. , Garstang , F. M. , Hodge , K. C. , Metcalfe , P. J. , Benzo , Z. , Hill , K. , Ralston , A. J. , Ball , J. and Denton , J. 1982 . Treatment of fracturing renal osteodystrophy by desferrioxamine . Proc. EDTA (Eur. Dial. Transplant. Assoc.) , 19 : 203 – 207 .
   Google Scholar
• Ackrill , P. , Ralston , A. J. and Day , J. P. 1986 . Role of desferrioxamine in the treatment of dialysis encephalopathy . Kidney Int. , 29 : S104 – S107 .
   Google Scholar
• Adhemar , J. P. , Laederich , J. , Jaudon , M. C. , Masselot , J. P. , Galli , A. and Kleinknecht , D. 1980 . Removal of aluminum from patients with dialysis encephalopathy . Lancet , ii : 1311
   Google Scholar
• Alfrey , A. C. , Hegg , A. and Craswell , P. 1980 . Metabolism and toxicity of aluminum in renal failure . Am. J. Clin. Nutr. , 33 : 1509 – 1516 .
   PubMed Web of Science ®Google Scholar
• Allain , P. , Chaleil , D. , Mauras , Y. , Beaudeau , G. , Varin , M. C. , Poignet , J. L. , Ciacioni , C. , Ang , K. S. , Cam , G. and Simon , P. 1987 . Pharmacokinetics of desferrioxamine and of its iron and aluminium chelates in patients on haemodialysis . Clin. Chim. Acta , 170 : 331 – 338 .
   PubMed Web of Science ®Google Scholar
• Allain , P. , Leblondel , G. and Mauras , Y. 1988 . Effect of aluminum and deferoxamine on biliary iron elimination in the rat . Proc. Soc. Exp. Biol. Med. , 188 : 471 – 473 .
   PubMed Web of Science ®Google Scholar
• Altmann , P. , Hamon , C. , Blair , J. , Dhanesha , U. , Cunningham , J. and Marsh , F. 1989 . Disturbance of cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity . Lancet , ii : 7 – 12 .
   Google Scholar
• Anderegg , G. and Raber , M. 1990 . Metal complex formation of a new siderophore desferrithiocin and of three related ligands . J. Chem. Soc. Chem. Commun. , : 1194 – 1196 .
   Google Scholar
• Andreoli , S. P. , Dunn , D. , DeMyer , W. , Sherrard , D. J. and Bergstein , J. M. 1985 . Intraperitioneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysis . J. Pediatr. , 107 : 760 – 763 .
   PubMed Web of Science ®Google Scholar
• Anghileri , L. J. 1992 . Ehrlich tumour cells: Ca2+‐uptake modification by aluminium lactate . Cell Calcium , 13 : 277 – 279 .
   PubMed Web of Science ®Google Scholar
• Anonymous . 1985 . Metal chelation therapy, oxygen radicals, and human disease . Lancet , i : 143 – 145 .
   Google Scholar
• Anthone , S. , Ambrus , C. M. , Horvath , C. and Kalghatgi , K. 1987 . Immobilized desferrioxamine (DFO) for the extracorporeal removal of aluminum . ASAIO Trans. (Am. Soc. Artif. Intern. Organs) , 33 : 744 – 748 .
   PubMedGoogle Scholar
• Arakelian , S. , D'Haese , P. C. , Vaneerdeweg , W. , Tjalma , W. , Babloyan , A. , Verpooten , G. A. and de Broe , M. E. 1990 . Biliary and renal kinetics of aluminoxamine and ferrioxamine in the dog . J. Am. Soc. Nephrol. , 1 : 322
   Google Scholar
• Arze , R. S. , Parkinson , I. S. , Cartlidge , N. E. F. , Britton , P. and Ward , M. K. 1981 . Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment . Lancet , ii : 1116
   Google Scholar
• Bakir , A. A. , Hryhorczuk , D. O. , Berman , E. and Dunea , G. 1986 . Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients . ASAIO Trans. (Am. Soc. Artif. Intern. Organs) , 32 : 171 – 176 .
   PubMedGoogle Scholar
• Barclay , S. J. , Riley , P. E. and Raymond , K. N. 1984 . Coordination chemistry of microbial iron transport compounds. 26. Dimeric dialkoxo‐bridged iron (III) complexes of linear dihydroxamate ligands . Inorg. Chem. , 23 : 2005 – 2010 .
   Web of Science ®Google Scholar
• Berdoukas , V. , Bentley , P. , Frost , H. and Schnebli , H. P. 1993 . Toxicity of oral iron cheltor L1 . Lancet , 341 : 1088
   PubMed Web of Science ®Google Scholar
• Bergeron , R. J. and Pegram , J. J. 1988 . An efficient total synthesis of desferrioxamine B . J. Organic Chem. , 53 : 3131 – 3134 .
   Web of Science ®Google Scholar
• Bertholf , R. L. , Herman , M. M. , Savory , J. , Carpenter , R. M. , Sturgill , B. C. , Katsetos , C. D. , VandenBerg , S. R. and Wills , M. R. 1989 . A long‐term intravenous model of aluminum maltol toxicity in rabbits: Tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure . Toxicol. Appl. Pharmacol. , 98 : 58 – 74 .
   PubMed Web of Science ®Google Scholar
• Berthon , G. and Daydé , S. 1992 . Why aluminum phosphate is less toxic than aluminum hydroxide . J. Am. Coll. Nutr. , 11 : 340 – 348 .
   PubMed Web of Science ®Google Scholar
• Bigay , J. , Deterre , P. , Pfister , C. and Chabre , M. 1987 . Fluoride complexes of aluminium or beryllium act on G‐proteins as reversibly bound analogues of the y phosphate of GTP . EMBO J. , 6 : 2907 – 2913 .
   PubMed Web of Science ®Google Scholar
• Bittar , E. E. , Xiang , Z. and Huang , Y.‐P. 1992 . Citrate as an aluminum chelator and positive effector of the sodium efflux in single barnacle muscle fibers . Biochim. Biophys. Acta , 1108 : 210 – 214 .
   PubMed Web of Science ®Google Scholar
• Boelaert , J. R. , Van Roost , G. F. , Vergauwe , P. L. , Verbanck , J. J. , de Vroey , C. and Segaert , M. F. 1988 . The role of desferrioxamine in dialysis‐associated mucormycosis: Report of three cases and review of the literature . Clin. Nephrol. , 29 : 261 – 266 .
   PubMed Web of Science ®Google Scholar
• Boelaert , J. R. , Fenves , A. Z. and Coburn , J. W. 1991 . Deferoxamine therapy and mucormycosis in dialysis patients: Report of an international registry . Am. J. Kidney Dis. , 18 : 660 – 667 .
   PubMed Web of Science ®Google Scholar
• Bott , S. G. , Elgamal , H. and Atwood , J. L. 1985 . Seven‐coordinate aluminum in [ALCL2#lbbenzo‐15‐crown‐5] [AICI3Et] . J. Am. Chem. Soc. , 107 : 1796 – 1797 .
   Web of Science ®Google Scholar
• Brown , D. J. , Ham , K. N. , Dawborn , J. K. and Xipell , J. M. 1982 . Treatment of dialysis osteomalacia with desferrioxamine . Lancet , ii : 343 – 345 .
   Google Scholar
• Brudevold , F. , Moreno , E. and Bakhos , Y. 1972 . Fluoride complexes in drinking water . Arch. Oral Biol. , 17 : 1155 – 1163 .
   PubMed Web of Science ®Google Scholar
• Burks , J. S. , Alfrey , A. C. , Huddlestone , J. , Norenberg , M. D. and Lewin , E. 1976 . A fatal encephalopathy in chronic haemodialysis patients . Lancet , i : 764 – 768 .
   Google Scholar
• Burnatowska‐Hledin , M. A. , Schwartz , K. , Kovan , J. and Mayor , G. 1985 . Effect of desferrioxamine (DFO) and ethylenediamine N,N'‐bis(2‐hydroxyphenylacetic) acid (EDBHPA) in aluminum (AL) loaded rats . Kidney Int. , 27 : 158
   Web of Science ®Google Scholar
• Burrows , W. D. 1977 . Aquatic aluminum: Chemistry, toxicology and environmental prevalence . CRC Crit. Rev. Environ. Control , 7 : 167 – 216 .
   Web of Science ®Google Scholar
• Canavese , C. , Pramotton , C. , Pacitti , A. , Segoloni , G. , Bedino , S. , Testore , G. , Lamon , S. and Talarico , S. 1986 . Aluminum chromatographic patterns after desferrioxamine infusion . Trace Hem, Med. , 3 : 93 – 94 .
   Google Scholar
• Canavese , C. , Pacitti , A. , Segoloni , G. , Thea , A. , D'Amicone , M. , Stratta , P. , Rossi , P. , Sabbioni , E. , Pietra , R. , Constantini , S. , Giordano , R. , Ballanti , P. , Mocetti , P. , Luda , E. and Bugiani , O. 1989 . Clinical and histological results of long‐term management of aluminium overloading in uraemic patients with desferrioxamine . J. Trace Elem. Electrol. Health Dis. , 3 : 17 – 23 .
   PubMed Web of Science ®Google Scholar
• Canavese , C. , Salomone , M. , Pacitti , A. , Mangiarotti , G. , Thea , A. , Dogliani , M. and Serra , A. 1991 . Concomitant iron and aluminum mass transfer following deferoxamine infusion during hemofiltration . Am. J. Kidney Dis. , 17 : 179 – 184 .
   PubMed Web of Science ®Google Scholar
• Carlier , M. F. , Didry , D. , Melki , R. , Chabre , M. and Pantaloni , D. 1988 . Stabilization of micro‐tubules by inorganic phosphate and its structural analogues, the fluoride complexes of aluminum and beryllium . Biochemistry , 27 : 3555 – 3559 .
   PubMed Web of Science ®Google Scholar
• Cases , A. , Campistol , J. M. , Sabater , M. , Lopez‐Pedret , J. and Revert , L. 1988 . Desferrioxamine‐induced acute neurosensorial deafness . Nephron , 48 : 326
   PubMed Web of Science ®Google Scholar
• Cases , A. , Kelly , J. , Sabater , F. , Torras , A. , Griño , M. C. , Lopez‐Pedret , J. and Revert , L. 1990 . Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine . Nephron , 56 : 19 – 23 .
   PubMed Web of Science ®Google Scholar
• Chang , T. M. S. and Barre , P. 1983 . Effect of desferrioxamine on removal of aluminium and iron by coated charcoal haemoperfusion and haemodialysis . Lancet , ii : 1051 – 1053 .
   Google Scholar
• Cianciono , C. , Poignet , J. L. , Mauras , Y. , Panthier , G. , Delons , S. , Allain , P. and Man , N. K. 1984 . Plasma aluminum and iron kinetics in hemodialyzed patients after iv infusion of desferrioxamine . ASAIO Trans. (Am. Soc. Artil. Intern. Organs) , 30 : 479 – 482 .
   PubMedGoogle Scholar
• Clevette , D. J. and Orvig , C. 1990 . Comparison of ligands of differing denticity and basicity for the in vivo chelation of aluminium and gallium . Polyhedron , 9 : 151 – 161 .
   Web of Science ®Google Scholar
• Clevette , D. J. , Nelson , W. O. , Nordin , A. , Orvig , C. and Sjöberg , S. 1989 . Complexation of aluminum with N‐substituted 3‐hydroxy‐4‐pyridinones . Inorganic Chem. , 28 : 2079 – 2081 .
   Google Scholar
• Coburn , J. W. , Mischel , M. G. , Goodman , W. G. and Salusky , I. B. 1991 . Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide . Am. J. Kidney Dis. , 17 : 708 – 711 .
   PubMed Web of Science ®Google Scholar
• Connor , D. J. , Harrell , L. E. and Jope , R. S. 1989 . Reversal of an aluminum‐induced behavioral deficit by administration of deferoxamine . Behavioral Neurosci. , 103 : 779 – 783 .
   PubMed Web of Science ®Google Scholar
• Cowburn , J. D. and Blair , J. A. 1989 . Aluminium chelator (transferrin) reverses biochemical deficiency in Alzheimer brain preparations . Lancet , i : 99
   Google Scholar
• Crapper , D. R. and Tomko , G. J. 1975 . Neuronal correlates of an encephalopathy associated with aluminum neurofibrillary degeneration . Brain Res. , 97 : 253 – 264 .
   PubMed Web of Science ®Google Scholar
• Crapper McLachlan , D. R. , Kruck , T. P. , Lukiw , W. J. and Krishnan , S. S. 1991a . Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? . Can. Med. Assoc. J. , 145 : 793 – 804 .
   Web of Science ®Google Scholar
• Crapper McLachlan , D. R. , Dalton , A. J. , Kruck , T. P. A. , Bell , M. Y. , Smith , W. L. , Kalow , W. and Andrews , D. F. 1991b . Intramuscular desferrioxamine in patients with Alzheimer's disease . Lancet , 337 : 1304 – 1308 .
   PubMed Web of Science ®Google Scholar
• Davenport , A. and Ahmed , R. 1988 . Grand mal fitting in a patient on regular haemodialysis treatment and receiving desferrioxamine therapy . Scand. J. Urol. Nephrol. , 22 : 159 – 160 .
   PubMed Web of Science ®Google Scholar
• Day , J. P. , Ackrill , P. , Garstang , F. M. , Hodge , K. C. , Metcalfe , P. J. , O'Hara , M. , Benzo , Z. and Romero‐Martinez , R. A. 1983 . “ Reduction of the body burden of aluminium in renal patients by desferrioxamine chelation therapy ” . In Chemical Toxicology and Clinical Chemistry of Metals , Edited by: Brown , S. S. and Savory , J. 353 – 356 . New York : Academic Press .
   Google Scholar
• Delavelle , F. , Richalet , B. , Malvy , F. and Fries , D. 1977 . Le traitment par I'EDTA des encéphalopathies “pseudo‐démentielles” chez les hénodialysés . Nouv. Press. Med. , 6 : 941 – 942 .
   PubMedGoogle Scholar
• Deloncle , R. , Guillard , O. , Clanet , F. , Courtois , P. and Piriou , A. 1990 . Aluminum transfer as glutamate complex through blood‐brain barrier . Biol. Trace Elem. Res. , 25 : 39 – 45 .
   PubMed Web of Science ®Google Scholar
• Domingo , J. L. , Llobet , J. M. , Gómez , M. and Corbella , J. 1986 . Acute aluminium intoxication: A study of the efficacy of several antidotal treatments in mice . Res. Commun. Chem. Pathol. Pharmacol. , 53 : 93 – 104 .
   PubMedGoogle Scholar
• Domingo , J. L. , Gómez , M. and Llobet , J. M. 1988a . Citric, malic and succinic acids as possible alternatives to deferoxamine in aluminum toxicity . J. Toxicol. Clin. Toxicol. , 26 : 67 – 79 .
   PubMed Web of Science ®Google Scholar
• Domingo , J. L. , Gómez , M. , Llobet , J. M. and Corbella , J. 1988b . Comparative effects of several chelating agents on the toxicity, distribution and excretion of aluminium . Human Toxicol. , 7 : 259 – 262 .
   PubMedGoogle Scholar
• Domingo , J. L. , Gomez , M. , Llobet , J. M. and Corbella , J. 1991a . Influence of some dietary constituents on aluminum absorption and retention in rats . Kidney Int. , 39 : 598 – 602 .
   PubMed Web of Science ®Google Scholar
• Domingo , J. L. , Gomez , M. , Llobet , J. M. and Richart , C. 1991b . Effect of ascorbic acid on gastrointestinal aluminium absorption . Lancet , 338 : 1467
   PubMed Web of Science ®Google Scholar
• Domingo , J. L. , Gomez , M. , Sanchez , D. J. , Llobet , J. M. and Corbella , J. 1993 . Effect of various dietary constituents on gastrointestinal absorption of aluminum from drinking water and diet . Res. Commun. Chem. Pathol. Pharmacol. , 79 : 377 – 380 .
   PubMedGoogle Scholar
• Driscoll , C. T. , Baker , J. P. , Bisogni , J. J. and Schofield , C. L. 1980 . Effect of aluminium speciation on fish in dilute acidified waters . Nature , 284 : 161 – 164 .
   Web of Science ®Google Scholar
• Ebina , Y. , Okada , S. , Hamazaki , S. and Midorikawa , O. 1984 . Liver, kidney, and central nervous system toxicity of aluminum given intrapertioneally to rats: A multiple‐dose subchronic study using aluminum nitrilotriacetate . Toxicol. Appl. Pharmacol. , 75 : 211 – 218 .
   PubMed Web of Science ®Google Scholar
• Ebina , Y. , Okada , S. , Hamazaki , S. , Toda , Y. and Midorikawa , O. 1991 . Impairment of bone formation with aluminum and ferric nitrilotriacetate complexes . Calcif. Tissue Int. , 48 : 28 – 36 .
   PubMed Web of Science ®Google Scholar
• Ecelbarger , C. A. and Greger , J. L. 1991 . Dietary citrate and kidney function affect aluminum, zinc and iron utilization in rats. 1991 . J. Nutr. , 121 : 1755 – 1762 .
   PubMed Web of Science ®Google Scholar
• Ellenberg , R. , King , A. L. , Sica , D. A. , Posner , M. and Savory , J. 1990 . Cerebrospinal fluid aluminum levels following deferoxamine . Am. J. Kidney Dis. , 16 : 157 – 159 .
   PubMed Web of Science ®Google Scholar
• Evers , A. , Hancock , R. D. , Martell , A. E. and Motekaitis , R. J. 1989 . Metal ion recognition in ligands with negatively charged oxygen donor groups. Complexation of Fe(III), Ga(III), In(III), Al(III), and other highly charged metal ions . Inorg. Chem. , 28 : 2189 – 2195 .
   Web of Science ®Google Scholar
• Fatemi , S. J. A. , Kadir , F. H. A. and Moore , G. R. 1991 . Aluminium transport in blood serum . Biochem. J. , 280 : 527 – 532 .
   PubMed Web of Science ®Google Scholar
• Favarato , M. , Mizzen , C. A. , Sutherland , M. K. , Krishnan , B. , Kruck , T. P. A. and Crapper McLachlan , D. R. 1992 . Aluminum‐binding serum proteins: desferrioxamine alters serum aluminum speciation . Clin. Chim. Acta , 207 : 41 – 55 .
   PubMed Web of Science ®Google Scholar
• Feng , T. L. , Gurian , P. L. , Healy , M. D. and Barron , A. R. 1990 . Aluminum citrate: Isolation and structural characterization of a stable trinuclear complex . Inorg. Chem. , 29 : 408 – 411 .
   Web of Science ®Google Scholar
• Finch , J. L. , Bergfeld , M. , Martin , K. J. , Chan , Y.‐L. , Teitelbaum , S. and Slatopolsky , E. 1986 . The effects of discontinuation of aluminum exposure on aluminum‐induced osteomalacia . Kidney Int. , 30 : 318 – 324 .
   PubMed Web of Science ®Google Scholar
• Finnegan , M. M. , Rettig , S. J. and Orvig , C. 1986 . A neutral water‐soluble aluminum comlex of neurological interest . J. Am. Chem. Soc. , 108 : 5033 – 5035 .
   Web of Science ®Google Scholar
• Finnegan , M. M. , Lutz , T. G. , Nelson , W. O. , Smith , A. and Orvig , C. 1987 . Neutral water‐soluble post‐transition‐metal chelate complexes of medical interest: Aluminum and gallium tris(3‐hydroxy‐4‐pyronates) . Inorg. Chem. , 26 : 2171 – 2176 .
   Web of Science ®Google Scholar
• Firestone , M. K. , Killham , K. and McColl , J. G. 1983 . Fungal toxicity of mobilized soil aluminum and manganese . Appl. Environ. Microbiol. , 46 : 758 – 761 .
   PubMed Web of Science ®Google Scholar
• Flaten , T. P. and Garruto , R. M. 1991 . Desferrioxamine for Alzheimer's disease . Lancet , 338 : 324 – 326 .
   Google Scholar
• Fontana , L. , Perazzolo , M. , Stella , M. P. , Tapparo , A. , Corain , B. , Favarato , M. and Zatta , P. 1991 . A long‐term toxicological investigation of the effect of tris(malto!ate)aluminum(III) in rabbits . Biol. Trace Elem. Res. , 31 : 183 – 191 .
   PubMed Web of Science ®Google Scholar
• Forbes , W. F. , Hayward , L. M. and Agwani , N. 1991 . Dementia, aluminium, and fluoride . Lancet , 338 : 1592 – 1593 .
   PubMed Web of Science ®Google Scholar
• Freedman , M. H. , Boyden , M. , Taylor , M. and Skarf , B. 1988 . Neurotoxicity associated with deferoxamine therapy . Toxicology , 49 : 283 – 290 .
   PubMed Web of Science ®Google Scholar
• Froment , D. Ph. , Molitoris , B. A. , Buddington , B. , Miller , N. and Alfrey , A. C. 1989 . Site and mechanism of enhanced gastrointestinal absorption of aluminum by citrate . Kidney Int. , 36 : 978 – 984 .
   PubMed Web of Science ®Google Scholar
• Fulton , B. and Jeffery , E. H. 1990 . Absorption and retention of aluminum from drinking water. 1. Effect of citric and ascorbic acids on aluminum tissue levels in rabbits . Fundam. Appl. Toxicol. , 14 : 788 – 796 .
   PubMedGoogle Scholar
• Garrison , J. M. and Crumbliss , A. L. 1987 . Kinetics and mechanism of aluminum(III)/siderophore ligand exchange: Mono(deferriferrioxamine B)aluminum(III) formation and dissociation in aqueous acid solution . Inorg. Chim. Acta , 138 : 61 – 65 .
   Web of Science ®Google Scholar
• Giordano , R. , Ioppolo , A. , Ciaralli , L. , Rubbiani , M. , Vernillo , I. and Costantini , S. 1989 . Aluminum removal after chronic intoxication in rats . Res. Commun. Chem. Pathol. Pharmacol. , 63 : 119 – 127 .
   PubMedGoogle Scholar
• Glynn , A. W. , Norrgren , L. and Malmborg , O. 1992 . The influence of calcium and humic substances on aluminium accumulation and toxicity in the minnow, phoxinus phoxinus, at low pH . Comp. Biochem. Physiol. , 102C : 427 – 432 .
   Google Scholar
• Gomez , M. , Domingo , J. M. , Llobet , J. M. and Corbella , J. 1990 . “ The use of desferrioxamine and other chelating agents in the treatment of aluminium overload in rats ” . In Metal Ions in Biology and Medicine , Edited by: Collery , P. , Poirier , L. A. , Manfait , M. and Etienne , J. C. 348 – 350 . Paris : John Libbey Eurotext .
   Google Scholar
• Gomez , M. , Domingo , J. L. and Llobet , J. M. 1991 . Developmental toxicity evaluation of oral aluminum in rats: Influence of citrate . Neurotoxicol. Teratol. , 13 : 323 – 328 .
   PubMed Web of Science ®Google Scholar
• Goodill , J. J. and Abuelo , J. G. 1987 . Mucormycosis—A new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload? . N. Engl. J. Med. , 317 : 54
   PubMed Web of Science ®Google Scholar
• Graf , H. , Stummvoll , H. K. , Meisinger , V. , Kovarik , J. , Wolf , A. and Pinggera , W. F. 1981 . Aluminum removal by hemodialysis . Kidney Int. , 19 : 587 – 592 .
   PubMed Web of Science ®Google Scholar
• Greger , J. L. and Powers , C. F. 1992 . Assessment of exposure to parenteral and oral aluminum with and without citrate using a desferrioxamine test in rats . Toxicology , 76 : 119 – 132 .
   PubMed Web of Science ®Google Scholar
• Gregor , J. E. and Powell , H. K. J. 1986 . Aluminum(III)‐citrate complexes: A potentionmetric and 13C N.M.R. study . Aust. J. Chem. , 39 : 1851 – 1864 .
   Web of Science ®Google Scholar
• Grossman , S. D. and Smith , L. E. 1988 . Correspondence . Am. J. Kidney Dis. , 11 : 362
   PubMedGoogle Scholar
• Guy , S. P. , Seabright , P. , Day , J. P. and Itzhaki , R. F. 1990 . Uptake of aluminium by human neuro‐blastoma cells . J. Trace Elem. Electrol. Health Dis. , 4 : 183 – 187 .
   PubMed Web of Science ®Google Scholar
• Harris , W. R. 1992 . Equilibrium model for speciation of aluminum in serum . Clin. Chem. , 38 : 1809 – 1818 .
   PubMed Web of Science ®Google Scholar
• Harris , W. R. and Sheldon , J. 1990 . Equilibrium constants for the binding of aluminum to human serum transferrin . Inorg. Chem. , 29 : 119 – 124 .
   Web of Science ®Google Scholar
• Haug , B. A. , Botsch , G. and Felgenhauer , K. 1991 . Speech dyspraxia in dialysis‐associated aluminium encephalopathy . Nervenarzt , 62 : 637 – 640 .
   PubMed Web of Science ®Google Scholar
• Hayes , P. , Martin , T. P. , Pybus , J. , Hunt , J. and Broadbent , R. S. 1992 . Reduction of bioavailability of aluminium in neonatal parenteral nutrition solutions by prior complexation in the dosage form . J. Parenteral Sci. Technol. , 46 : 169 – 175 .
   PubMedGoogle Scholar
• Hedlund , T. and Ohman , L.‐O. 1988 . Equilibrium and structural studies of silicon(IV) and aluminium (III) in aqueous solution. 19. Composition and stability of aluminium complexes with kojic acid and maltol . Acta Chem. Scand. A. , 42 : 702 – 709 .
   Google Scholar
• Hem , J. D. 1967 . Graphical methods for studies of aqueous aluminum hydroxide, fluoride, and sulfate complexes . Geol. Surv. Water‐Supply Paper , : B1 – B33 . USGPO 1827‐B
   Google Scholar
• Hercz , G. , Salusky , I. B. , Norris , K. C. , Fine , R. N. and Coburn , J. W. 1986 . Aluminum removal by peritoneal dialysis: Intravenous vs. intraperitoneal deferoxamine . Kidney Int. , 30 : 944 – 948 .
   PubMed Web of Science ®Google Scholar
• Hernandez , P. and Johnson , C. A. 1990 . Deferoxamine for aluminum toxicity in dialysis patients . Am. Nephorol. Nurses’ Assoc. J. , 17 : 224 – 228 .
   Google Scholar
• Hess , T. , Gautschi , K. , Jungbluth , H. and Binswanger , U. 1984 . Incorporation of aluminium and effect of removal in experimental osteomalacia and fibro‐osteoclasia . Proc. EDTA‐ERA (Eur. Dial. Transplant Assoc.‐Eur. Renal Assoc.) , 21 : 387 – 389 .
   Google Scholar
• Hewitt , S. D. , Hider , R. C. , Sarpong , P. , Morris , C. J. and Blake , D. R. 1989 . Investigation of the anti‐inflammatory properties of hydroxypyridionones . Ann. Rheum. Dis. , 48 : 382 – 388 .
   PubMed Web of Science ®Google Scholar
• Hewitt , C. D. , Herman , M. M. , Lopes , M. B. S. , Savory , J. and Wills , M. R. 1991 . Aluminium maltol‐induced neurocytoskeletal changes in fetal rabbit midbrain in matrix culture . Neuropathol. Appl. Neurobiol. , 17 : 47 – 60 .
   PubMed Web of Science ®Google Scholar
• Hider , R. C. and Hall , A. D. 1991 . Clinically useful chelators of tripositive elements . Prog. Medicinal Chem. , 28 : 41 – 173 .
   PubMedGoogle Scholar
• Hobbs , C. S. , Moorman , R. P. , Griffith , J. M. , West , J. L. , Merriman , G. M. , Hansard , S. L. , Chamberlain , C. C. , MacIntire , W. H. , Hardin , L. J. and Jones , L. S. 1954 . Fluorosis in cattle and sheep , Bull. No. 235 Knoxville, Tenn. : University of Tennessee Agr. Exp. Station .
   Google Scholar
• Hogfeldt , E. , ed. 1976 . Stability Constants of Metal‐Ion Complexes, 2nd Supplement, Part A. Inorganic Ligands , IUPAC Chemistry Data Series No. 22
   Google Scholar
• Housely , P. R. 1990 . Aluminum fluoride inhibition of glucocorticoid receptor inactivation and transformation . Biochemistry , 29 : 3578 – 3585 .
   PubMed Web of Science ®Google Scholar
• Huang , Y.‐P. and Bittar , E. E. 1991 . Protection by GTP from the effects of aluminum on the sodium efflux in barnacle muscle fibers . Biochim. Biophys. Acta , 1062 : 255 – 263 .
   PubMedGoogle Scholar
• Hue , N. V. , Craddock , G. R. and Adams , F. 1986 . Effect of organic acids on aluminum toxicity in subsoils . Soil Sci. Soc. Am. J. , 50 : 28 – 34 .
   Web of Science ®Google Scholar
• Hundt , T. R. and O'Melia , C. R. 1988 . Aluminum‐fulvic acid interactions: Mechanisms and applications . J. Am. Water Works Assoc. , 80 : 176 – 186 .
   Web of Science ®Google Scholar
• Ihle , B. U. , Buchanan , M. R. C. , Stevens , B. , Becker , G. J. and Kincaid‐Smith , P. 1982 . The efficacy of various treatment modalities on aluminium associated bone disease . Proc. EDTA (Eur. Dial. Transplant Assoc.) , 19 : 195 – 202 .
   Google Scholar
• Ittel , T. H. , Griessner , A. and Sieberth , H. G. 1991 . Effect of lactate on the absorption and retention of aluminum in the remnant kidney rat model . Nephron , 57 : 332 – 339 .
   PubMed Web of Science ®Google Scholar
• Ittel , T. H. , Gruber , E. , Heinrichs , A. , Handt , S. , Hofstädter , F. and Siebert , H.‐G. 1992 . Effect of fluoride on aluminum‐induced bone disease in rats with renal failure . Kidney Int. , 41 : 1340 – 1348 .
   PubMed Web of Science ®Google Scholar
• Jackson , G. E. 1982 . Studies on the chelation of aluminium for biological application. Part 1. Citric acid . S. Afr. J. Chem. , 35 : 89 – 92 .
   Google Scholar
• Jackson , G. E. and Cosgrove , A. 1982 . Studies on the chelation of aluminium for biological application. Part 2. Oxalic, malonic, and succinic acids . S. Air. J. Chem. , 35 : 93 – 95 .
   Google Scholar
• Jones , M. M. 1984 . Antagonists for toxic heavy metals . Proc. West. Pharmacol. Soc. , 27 : 163 – 167 .
   PubMedGoogle Scholar
• Jøns , O. and Johansen , E. S. 1988 . Formation of aluminium and zinc complexes with picolinic acid. A potentiometric investigation . Inorg. Chim. Acta , 151 : 129 – 132 .
   Web of Science ®Google Scholar
• Katsetos , C. D. , Savory , J. , Herman , M. M. , Carpenter , R. M. , Frankfurter , A. , Hewitt , C. D. and Wills , M. R. 1990 . Neuronal cytoskeletal lesions induced in the CNS by intraventricular and intravenous aluminium maltol in rabbits . Neuropathol. Appl. Neurobiol. , 16 : 511 – 528 .
   PubMed Web of Science ®Google Scholar
• Khalil‐Manesh , F. , Agness , C. and Gonick , H. C. 1989 . Aluminum‐binding protein in dialysis dementia . Nephron , 52 : 323 – 328 .
   PubMed Web of Science ®Google Scholar
• King , R. G. 1984 . Do raised brain aluminium levels in Alzheimer's dementia contribute to cholingeric neuronal deficits? . Med. Hypotheses , 14 : 301 – 306 .
   PubMedGoogle Scholar
• King , R. G. and Worland , H. J. 1985 . Desferrioxamine and Alzheimer's dementia . Med. J. Aust. , 142 : 352
   PubMed Web of Science ®Google Scholar
• Kirschbaum , B. B. and Schoolwerth , A. C. 1989a . Acute aluminum toxicity associated with oral citrate and aluminum‐containing antacids . Am. J. Med. Sci. , 297 : 9 – 11 .
   PubMed Web of Science ®Google Scholar
• Kirschbaum , B. B. and Schoolwerth , A. C. 1989b . Hyperaluminaemia associated with oral citrate and aluminium hydroxide . Hum. Toxicol. , 8 : 45 – 47 .
   PubMedGoogle Scholar
• Kiss , T. , Sóvágó , I. and Martin , R. B. 1989 . Complexes of 3,4‐dihydroxyphenyl derivatives. 9. Al3+binding to catecholamines and tiron . J. Am. Chem. Soc. , 111 : 3611 – 3614 .
   Web of Science ®Google Scholar
• Konishi , S. and Miyamoto , S. 1983 . Alleviation of aluminum stress and stimulation of tea pollen tube growth by fluorine . Plant Cell Physiol. , 24 : 857 – 862 .
   Web of Science ®Google Scholar
• Kortus , J. and Mayer , J. 1968 . Verteilung des aluminiums im organismus bei erhohter zufuhr von aluminium‐ und fluor‐ionen . Die Nahrung , 12 : 441 – 448 .
   Google Scholar
• Kretchmar , S. A. and Raymond , K. N. 1986 . Biphasic kinetics and temperature dependence of iron removal from transferrin by 3,4‐LICAMS . J. Am. Chem. Soc. , 108 : 6212 – 6218 .
   Web of Science ®Google Scholar
• Kruck , T. P. A. and Crapper McLachlan , D. R. 1989 . “ Aluminum as a pathogenic factor in senile dementia of the Alzheimer type: Ion specific chelation ” . In Alzheimer's Disease and Related Disorders , Prog. Clin. Biol. Res. Edited by: Iqbal , K. vol. 317 , 1155 – 1167 . New York : Alan R. Liss .
   Google Scholar
• Kurokawa , K. , Marumo , F. , Ogura , Y. , Ono , T. and Suzuki , M. 1987 . “ Aluminum‐associated bone disease: Considerations on the pathogenesis and the effects of deferoxamine treatment ” . In Toxicology and Metals Clinical and Experimental Research , Edited by: Brown , S. S. and Kodama , Y. 211 – 217 . New York : John Wiley and Sons .
   Google Scholar
• Langui , D. , Probst , A. , Anderton , B. , Brion , J.‐P. and Ulrich , J. 1990 . Aluminium‐induced tangles in cultured rat neurones. Enhanced effect of aluminium by addition of maltol . Acta Neuropathol. , 80 : 649 – 655 .
   PubMedGoogle Scholar
• Lee , B. H. , Miller , M. J. , Prody , C. A. and Neilands , J. B. 1985a . Artificial siderophores. 1. Synthesis and microbial iron transport capabilities . J. Med. Chem. , 28 : 317 – 323 .
   PubMed Web of Science ®Google Scholar
• Lee , B. H. , Miller , M. J. , Prody , C. A. and Neilands , J. B. 1985b . Artificial siderophores. 2. Syntheses of trihydroxamate analogues of rhodotorulic acid and their biological iron transport capabilities in Escherichia coli . Med. Chem. , 28 : 323 – 327 .
   Web of Science ®Google Scholar
• Leung , F. Y. , Hodsman , A. B. , Muirhead , N. and Henderson , A. R. 1985 . Ultrafiltration studies in vitro of serum aluminum in dialysis patients after deferoxamine chelation therapy . Clin. Chem. , 31 : 20 – 23 .
   PubMed Web of Science ®Google Scholar
• Leung , F. Y. , Niblock , A. E. , Bradley , C. and Henderson , A. R. 1988 . Speciation studies of serum aluminum/citrate complex by liquid chromatography‐furnace AAS . Sci. Total Environ. , 71 : 49 – 56 .
   PubMed Web of Science ®Google Scholar
• Levin , V. A. 1980 . Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability . J. Med. Chem. , 23 : 682 – 684 .
   PubMed Web of Science ®Google Scholar
• Lillevang , S. T. and Pedersen , F. B. 1989 . Exacerbation of aluminium encephalopathy after treatment with desferrioxamine . Nephrol. Dial. Transplant , 4 : 676
   PubMed Web of Science ®Google Scholar
• Lind , C. J. and Hem , J. D. 1975 . Chemistry of aluminum in natural water. Effects of organic solutes on chemical reactions of aluminum , Geol. Surv. Water‐Supply Paper 1827‐G G1 – G83 .
   Google Scholar
• Llobet , J. M. , Domingo , J. L. , Gómez , M. , Tomás , J. M. and Corbella , J. 1987 . Acute toxicity studies of aluminium compounds; antidotal efficacy of several chelating agents . Pharmacol. Toxicol. , 60 : 280 – 283 .
   PubMedGoogle Scholar
• Lloyd , J. B. , Cable , H. and Rice‐Evans , C. 1991 . Evidence that desferrioxamine cannot enter cells by passive diffusion . Biochem. Pharmacol. , 41 : 1361 – 1363 .
   PubMed Web of Science ®Google Scholar
• Lomaestro , B. M. and Bailie , G. R. 1991 . Quinolone‐cation interactions: A review . DICP Ann. Pharmacother. , 25 : 1249 – 1258 .
   PubMedGoogle Scholar
• Lutz , T. G. , Clevette , D. J. , Rettig , S. J. and Orvig , C. 1989 . Metal chelation with natural products: Isomaltol complexes of aluminum, gallium, and indium . Inorg. Chem. , 28 : 715 – 719 .
   Web of Science ®Google Scholar
• Main , J. and Ward , M. K. 1992 . Potentiation of aluminium absorption by effervescent analgesic tablets in a haemodialysis patient . Br. Med. J. , 304 : 1686
   PubMedGoogle Scholar
• Malcolm , R. L. and McCracken , R. J. 1968 . Canopy drip: A source of mobile soil organic matter for mobilization of iron and aluminum . Proc. Soil Sci. Soc. Am. , 32 : 834 – 838 .
   Web of Science ®Google Scholar
• Malluche , H. H. , Smith , A. J. , Abreo , K. and Faugere , M.‐C. 1984 . The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure . N. Engl. J. Med , 311 : 140 – 144 .
   PubMed Web of Science ®Google Scholar
• Marklund , E. and Ohman , L.‐O. 1990 . Equilibrium and structural studies of silicon(IV) and aluminium (III) in aqueous solution. 24. A potentiometric and 27Al NMR study of polynuclear aluminium (III) hydroxo complexes with lactic acid . Acta Chem. Scand. , 44 : 228 – 234 .
   Google Scholar
• Marklund , E. , Sjöberg , S. and Öhman , L.‐O. 1986 . Equilibrium and structural studies of silicon(IV) and aluminium(III) in aqueous solution. 14. Speciation and equilibria in the aluminium (III)‐lactic acid‐OH‐ system . Acta Chem. Scand. A. , 40 : 367 – 373 .
   Google Scholar
• Marklund , E. , Öhman , L.‐O. and Sjöberg , S. 1989 . Equilibrium and structural studies of silicon(IV) and aluminium(III) in aqueous solution. 20. Composition and stability of aluminium complexes with propionic acid and acetic acid . Acta Chem. Scand. , 43 : 641 – 646 .
   Google Scholar
• Marques , H. M. 1991 . Kinetics of the release of aluminum from human serum dialuminum trans‐ferrin to citrate . J. Inorg. Biochem. , 41 : 187 – 193 .
   PubMed Web of Science ®Google Scholar
• Martell , A. E. and Smith , R. M. , eds. 1974 . Critical Stability Constants, vol. 1, Amino Acids , vol. 1 , New York : Plenum Press .
   Google Scholar
• Martell , A. E. and Smith , R. M. , eds. 1975 . Critical Stability Constants, vol. 2, Amines , vol. 2 , New York : Plenum Press .
   Google Scholar
• Martell , A. E. and Smith , R. M. , eds. 1976 . Critical Stability Constants, vol. 4, Inorganic Complexes , vol. 4 , New York : Plenum Press .
   Google Scholar
• Martell , A. E. and Smith , R. M. , eds. 1977 . Critical Stability Constants, vol. 3, Other Organic Ligands , vol. 3 , New York : Plenum Press .
   Google Scholar
• Martell , A. E. and Smith , R. M. , eds. 1982 . Critical Stability Constants, vol. 5, First Supplement , vol. 5 , New York : Plenum Press .
   Google Scholar
• Martell , A. E. , Motekaitis , R. J. and Smith , R. M. 1990 . Aluminium complexes of hydroxyaliphatic and hydroxyaromatic ligands in aqueous systems—Some problems and solutions . Polyhedron , 9 : 171 – 187 .
   Web of Science ®Google Scholar
• Martin , R. B. 1986 . Citrate binding of Al3+ and Fe3+ . J. Inorg. Biochem. , 28 : 181 – 187 .
   PubMed Web of Science ®Google Scholar
• Martin , R. B. , Savory , J. , Brown , S. , Bertholf , R. L. and Wills , M. R. 1987 . Transferrin binding of Al3+ and Fe3+ . Clin. Chem. , 33 : 405 – 407 .
   PubMed Web of Science ®Google Scholar
• May , P. M. and Bulman , R. A. 1983 . The present status of chelating agents in medicine . Prog. Medicinal Chem. , 20 : 225 – 336 .
   PubMedGoogle Scholar
• Mazzaferro , S. , Coen , G. , Ballanti , P. , Costantini , S. , Bondatti , F. , Giordano , R. , Manni , M. , Pasquali , M. , Perruzza , I. , Sardella , D. and Bonucci , E. 1992 . Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum‐related bone disease . Nephron , 61 : 151 – 157 .
   PubMed Web of Science ®Google Scholar
• McCarthy , J. T. , Kurtz , S. B. and Mussman , G. V. 1987 . Deferoxamine‐enhanced fecal losses of aluminum and iron in a patient undergoing continuous ambulatory peritoneal dialysis . Am. J. Med. , 82 : 367 – 370 .
   PubMed Web of Science ®Google Scholar
• McCarthy , J. T. , Milliner , D. S. , Schmidt , D. F. , Schniepp , B. J. , Kurtz , S. B. and Johnson , W. J. 1988 . Deferoxamine and coated charcoal hemoperfusion to remove aluminum in dialysis patients . Kidney Int. , 34 : 804 – 808 .
   PubMed Web of Science ®Google Scholar
• McCarthy , J. T. , Milliner , D. S. and Johnson , W. J. 1990 . Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity . Q. J. Med. New Ser. , 74 : 257 – 276 .
   PubMedGoogle Scholar
• McCauley , J. and Sorkin , M. I. 1989 . Exacerbation of aluminium encephalopathy after treatment with desferrioxamine . Nephrol. Dial. Transplant. , 4 : 110 – 114 .
   PubMed Web of Science ®Google Scholar
• McGonigle , R. J. S. and Parsons , V. 1985 . Aluminium‐induced anaemia in haemodialysis patients . Nephron , 39 : 1 – 9 .
   PubMedGoogle Scholar
• McGregor , S. J. , Brock , J. H. and Halls , D. 1991 . The role of transferrin and citrate in cellular uptake of aluminium . Biol. Metals , 4 : 173 – 175 .
   PubMed Web of Science ®Google Scholar
• Melograna , J. M. and Yokel , R. A. 1983 . Effect of the chelator desferrioxamine on aluminum elimination in rabbits . Res. Commun. Chem. Pathol. Pharmacol. , 40 : 497 – 509 .
   PubMedGoogle Scholar
• Melograna , J. M. and Yokel , R. A. 1984 . Effects of subchronic desferrioxamine infusion on aluminum toxicity in rabbits . Res. Commun. Chem. Pathol. Pharmacol. , 44 : 411 – 422 .
   PubMedGoogle Scholar
• Middleton , R. B. and Day , J. P. 1989 . Concentration and speciation of blood copper in renal dialysis patients with aluminium intoxication . J. Inorg. Biochem. , 36 : 349
   Google Scholar
• Mikulski , C. M. , Cocco , S. , Mattucci , L. , Defranco , N. and Weiss , L. 1982 . Aluminum chloride complexes with purine, adenine and guanine . Inorg. Chim. Acta , 67 : 173 – 175 .
   Web of Science ®Google Scholar
• Milliner , D. S. , Nebeker , H. G. , Ott , S. M. , Andress , D. L. , Sherrard , D. J. , Alfrey , A. C. , Slatopolsky , E. A. and Coburn , J. W. 1984 . Use of the deferoxamine infusion test in the diagnosis of aluminum‐related osteodystrophy . Ann. Intern. Med. , 101 : 775 – 780 .
   PubMed Web of Science ®Google Scholar
• Milliner , D. S. , Hercz , G. , Miller , J. H. , Shinaberger , J. H. , Nissenson , A. R. and Coburn , J. W. 1986 . Clearance of aluminum by hemodialysis: Effect of desferrioxamine . Kidney Int. , 29 (suppl. 18) : S100 – S103 .
   Google Scholar
• Milne , F. J. , Sharf , B. , Bell , P. D. and Meyers , A. M. 1982 . Low aluminium water, desferrioxamine, and dialysis encephalopathy . Lancet , ii : 502
   Google Scholar
• Milne , F. J. , Sharf , B. , Bell , P. and Meyers , A. M. 1983 . The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy . Clin. Nephrol. , 20 : 202 – 207 .
   PubMed Web of Science ®Google Scholar
• Miyasaka , S. C. , Buta , J. G. , Howell , R. K. and Foy , C. D. 1991 . Mechanism of aluminum tolerance in snapbeans. Root exudation of citric acid . Plant Physiol. , 96 : 737 – 743 .
   PubMed Web of Science ®Google Scholar
• Molitoris , B. A. , Alfrey , P. S. , Miller , N. L. , Hasbargen , J. A. , Kaehney , W. D. , Alfrey , A. C. and Smith , B. J. 1987 . Efficacy of intramuscular and intraperitoneal deferoxamine for aluminum chelation . Kidney Int. , 31 : 986 – 991 .
   PubMed Web of Science ®Google Scholar
• Molitoris , B. A. , Alfrey , A. C. , Alfrey , P. S. and Miller , N. L. 1988 . Rapid removal of DFO‐chelated aluminum during hemodialysis using polysulfone dialyzers . Kidney Int. , 34 : 98 – 101 .
   PubMed Web of Science ®Google Scholar
• Molitoris , B. A. , Froment , D. H. , Mackenzie , T. A. , Huffer , W. H. and Alfrey , A. C. 1989 . Citrate: A major factor in the toxicity of orally adminstered aluminum compounds . Kidney Int. , 36 : 949 – 953 .
   PubMed Web of Science ®Google Scholar
• Motekaitis , R. J. and Martell , A. E. 1984 . Complexes of aluminum(III) with hydroxy carboxylic acids . Inorg. Chem. , 23 : 18 – 23 .
   Web of Science ®Google Scholar
• Muramoto , S. 1981 . Influence of complexans (NTA, EDTA) on the toxicity of aluminum chloride and sulfate to fish at high concentrations . Bull. Environ. Contam. Toxicol. , 27 : 221 – 225 .
   PubMed Web of Science ®Google Scholar
• Navarro , J. A. , Granadillo , V. A. , Rodrígues‐Iturbe , B. , García , R. , Salgado , O. and Romero , R. A. 1991 . Removal of trace metals by continuous ambulatory peritoneal dialysis after desferrioxamine B chelation therapy . Clin. Nephrol. , 35 : 213 – 217 .
   PubMed Web of Science ®Google Scholar
• Nebeker , H. G. , Andress , D. L. , Milliner , D. S. , Ott , S. M. , Alfrey , A. C. , Slatopolsky , E. A. , Sherrard , D. J. and Coburn , J. W. 1986 . Indirect methods for the diagnosis of aluminum bone disease: Plasma aluminum, the desferrioxamine infusion test, and serum iPTH . Kidney Int. , 29 (suppl. 18) : S‐96 – S‐99 .
   Google Scholar
• Neet , K. E. , Furman , T. C. and Hueston , W. J. 1982 . Activation of yeast hexokinase by chelators and the enzymic slow transition due to metal‐nucleotide interactions . Arch. Biochem. Biophys. , 213 : 14 – 25 .
   PubMed Web of Science ®Google Scholar
• Nelson , D. J. and Martin , R. B. 1991 . Speciation in systems containing aluminum, nucleoside diphosphates, and fluoride . J. Inorganic Biochem. , 43 : 37 – 43 .
   Web of Science ®Google Scholar
• Nelson , W. O. , Lutz , T. G. and Orvig , C. 1989a . “ The chemistry of neurologically active, neutral, and water soluble aluminum complexes ” . In Environmental Chemistry and Toxicology of Aluminum , Edited by: Lewis , T. E. 271 – 287 . Chelsea, Mich. : Lewis .
   Google Scholar
• Nelson , W. O. , Rettig , S. J. and Orvig , C. 1989b . Aluminum and gallium complexes of 1‐ethyl‐3‐hydroxy‐2‐methyl‐4‐pyridinone: A new exoclathrate matrix . Inorg. Chem. , 28 : 3153 – 3157 .
   Web of Science ®Google Scholar
• Netter , P. , Kessler , M. , Gaucher , A. and Bannwarth , B. 1990 . Does aluminium have a pathogenic role in dialysis associated arthropathy? . Ann. Rheum. Dis. , 49 : 573 – 575 .
   PubMed Web of Science ®Google Scholar
• Nolan , C. R. , Califano , J. R. and Butzin , C. A. 1990 . Influence of calcium acetate or calcium citrate on intestinal aluminum absorption . Kidney Int. , 38 : 937 – 941 .
   PubMed Web of Science ®Google Scholar
• Ogborn , M. R. , Dorcas , V. C. and Crocker , J. F. S. 1991 . Deferoxamine and aluminum clearance in pediatric hemodialysis patients . Pediatr. Nephrol. , 5 : 62 – 64 .
   PubMed Web of Science ®Google Scholar
• Öhman , L.‐O. 1988 . Equilibrium and structural studies of silicon(IV) and aluminum(III) in aqueous solution. 17. Stable and metastable complexes in the system H´‐Al3+‐citric acid . Inorg. Chem. , 27 : 2565 – 2570 .
   Web of Science ®Google Scholar
• Öhman , L.‐O. 1990 . Equilibrium and structural studies of silicon(IV) and aluminium(III) in adqueous solution—XXIII. A potentiometric study of the composition and stability of aluminium complexes with nitrilotriacetic acid . Polyhedron , 9 : 199 – 205 .
   Web of Science ®Google Scholar
• Öhman , L.‐O. and Sjöberg , S. 1983a . Equilibrium and structural studies of silicon(IV) and aluminium(III) in aqueous solution. 8. A potentiometric study of aluminium(III) salicylates and aluminium(III) hydroxo salicylates in 0.6 M Na(Cl) . Acta Chem. Scand. A , 37 : 875 – 880 .
   Google Scholar
• Öhman , L.‐O. and Sjöberg , S. 1983b . Equilibrium and structural studies of silicon(IV) and aluminium(III) in aqueous solution. Part 9. A potentiometric study of mono‐ and poly‐nuclear aluminium(III) citrates . J. Chem. Soc. Dalton Trans. , : 2513 – 2517 .
   Google Scholar
• Ojima , K. , Abe , H. and Ohira , K. 1984 . Release of citric acid into the medium by aluminum‐tolerant carrot cells . Plant Cell Physiol. , 25 : 855 – 858 .
   Web of Science ®Google Scholar
• Olivieri , N. F. , Buncic , J. R. , Chew , E. , Gallant , T. , Harrison , R. V. , Keenan , N. , Logan , W. , Mitchell , D. , Ricci , G. , Skarf , B. , Taylor , M. and Freedman , M. H. 1986 . Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions . New Engl. J. Med. , 314 : 869 – 873 .
   PubMed Web of Science ®Google Scholar
• Ondreička , R. , Kortus , J. and Ginter , E. 1971 . “ Aluminum, its absorption, distribution, and effects on phosphorus metabolism ” . In Intestinal Absorption of Metal Ions, Trace Elements and Radionuclides , Edited by: Skoryna , S. C. and Waldron‐Edward , D. 293 – 305 . Oxford : Pergamon .
   Google Scholar
• Ott , S. M. , Maloney , N. A. , Coburn , J. W. , Alfrey , A. C. and Sherrard , D. J. 1982 . The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy . N. Engl. J. Med. , 307 : 709 – 713 .
   PubMed Web of Science ®Google Scholar
• Ownby , J. D. and Popham , H. R. 1989 . Citrate reverses the inhibition of wheat root growth caused by aluminum . J. Plant Physiol. , 135 : 588 – 591 .
   Web of Science ®Google Scholar
• Partridge , N. A. , Regnier , F. E. , White , J. L. and Hem , S. L. 1989 . Influence of dietary constituents on intestinal absorption of aluminum . Kidney Int. , 35 : 1413 – 1417 .
   PubMed Web of Science ®Google Scholar
• Payton , C. D. , Junor , B. J. R. and Fell , G. S. 1984 . Successful treatment of aluminium encephalopathy by intraperitoneal desferrioxamine . Lancet , i : 1132 – 1133 .
   Google Scholar
• Pearson , R. E. , ed. 1973 . Hard and Soft Acids and Bases , Stroudsburg, Pa. : Dowden, Hutchinson and Ross .
   Google Scholar
• Pecci , J. and Foye , W. O. 1960 . The avidity of salicylate, gentisic, and salicyluric acids for many heavy metal cations . J. Am. Pharm. Assoc. Sci. Ed. , 49 : 411 – 414 .
   Google Scholar
• Pedersen , C. J. and Frensdorff , H. K. 1972 . Macrocyclic polyethers and their complexes . Angew. Chem. Int. Ed. Engl. , 11 : 16 – 25 .
   PubMed Web of Science ®Google Scholar
• Pei , Y. , Hercz , G. , Greenwood , C. , Sherrard , D. , Segre , G. , Manuel , A. , Saiphoo , C. and Fenton , S. 1992 . Non‐invasive prediction of aluminum bone disease in hemo‐ and peritoneal dialysis patients . Kidney Int. , 41 : 1374 – 1382 .
   PubMed Web of Science ®Google Scholar
• Pérez Parajón , J. , González , E. B. , Cannata , J. B. and Medel , A. S. 1989 . A critical appraisal of the speciation of aluminum in serum by ultrafiltration . Trace Elem. Med. , 6 : 41 – 46 .
   Web of Science ®Google Scholar
• Perrin , D. D. , ed. 1979 . Stability Constants of Metal‐Ion Complexes, 2nd Supplement, Part B. Organic Ligands , IUPAC Chemistry Data Series No. 22
   Google Scholar
• Pierides , A. M. , Edwards , W. G. , Cullum , U. X. , McCall , J. T. and Ellis , H. A. 1980 . Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness . Kidney Int. , 18 : 115 – 124 .
   PubMed Web of Science ®Google Scholar
• Pogglitsch , H. , Petek , W. , Wawschinek , O. and Holzer , W. 1981 . Treatment of early stages of dialysis encephalopathy by aluminium depletion . Lancet , ii : 1344 – 1345 .
   Google Scholar
• Porter , J. B. , Huehns , E. R. and Hider , R. C. 1989 . The development of iron chelating drugs . Bailliere's Clin. Haematol. , 2 : 257 – 292 .
   PubMedGoogle Scholar
• Rajan , K. S. , Mainer , S. and Davis , J. M. 1978 . Studies on chelation of L‐DOPA with metal ions and metal‐ATP systems . Bioinorg. Chem. , 9 : 187 – 203 .
   Google Scholar
• Rajan , K. S. , Mainer , S. , Rajan , N. L. and Davis , J. M. 1981 . Studies on the chelation of aluminum for neurobiological application . J. Inorg. Biochem. , 14 : 339 – 350 .
   PubMed Web of Science ®Google Scholar
• Rao , G. A. R. and Srinivasulu , K. 1981 . Evaluation of interaction parameter and hence stoichiometry in the complexes of all‐cis‐1,2,3/4‐cyclopentanetetracarboxylic acid with some di‐ and trivalent metals . J. Ind. Chem. Soc. , 58 : 129 – 130 .
   Web of Science ®Google Scholar
• Ratz , P. H. and Blackmore , P. F. 1990 . Differential activation of rabbit femoral arteries by aluminum fluoride and sodium fluoride . J. Pharmacol. Exp. Ther. , 254 : 514 – 520 .
   PubMed Web of Science ®Google Scholar
• Roger , S. D. , Stewart , J. H. and Harris , D. C. H. 1991 . Desferrioxamine enhances the haemopoietic response to erythropoietin, but adverse events are common . Nephron , 58 : 33 – 36 .
   PubMed Web of Science ®Google Scholar
• Rosenkrantz , H. , Metterville , J. J. and Fleischman , R. W. 1986 . Preliminary toxicity findings in dogs and rodents given the iron chelator ethylenediamine‐N,N'‐bis(2‐hydroxyphenylacetic acid) (EDHPA) . Fundam. Appl. Toxicol. , 6 : 292 – 298 .
   PubMedGoogle Scholar
• Rovelli , E. , Luciani , L. , Pagani , C. , Albonico , C. , Colleoni , N. and D'Amico , G. 1988 . Correlation between serum aluminum concentration and signs of encephalopathy in a large population of patients dialyzed with aluminum‐free fluids . Clin. Nephrol. , 29 : 294 – 298 .
   PubMed Web of Science ®Google Scholar
• Rubinstein , M. , Dupont , P. , Doppee , J. P. , Dehon , C. , Ducobu , J. and Hainaut , J. 1985 . Ocular toxicity of desferrioxamine . Lancet , i : 817 – 818 .
   Google Scholar
• Rudy , D. , Sica , D. A. , Comstock , T. , Davis , J. , Savory , J. and Schoolwerth , A. C. 1991 . Aluminum‐citrate interaction in end‐stage renal disease . Int. J. Artif. Organs , 14 : 625 – 629 .
   PubMed Web of Science ®Google Scholar
• Russo , L. S. , Beale , G. , Sandroni , S. and Ballinger , W. E. 1992 . Aluminum intoxication in undialysed adults with chronic renal failure . J. Neurol. Neurosurg. Psychiat. , 55 : 697 – 700 .
   PubMed Web of Science ®Google Scholar
• Sawhney , S. S. and Bansal , A. K. 1983 . Thermodynamics of metal‐phenoxymethylpenicillin systems . Thermochim. Acta , 60 : 229 – 233 .
   Web of Science ®Google Scholar
• Schulz , W. , Deuber , H.‐J. and Pöpperl , G. 1984 . On the differential diagnosis and therapy of dialysis osteomalacia under special consideration to a therapy with oral phosphate binders . Trace Elem. Med. , 1 : 120 – 127 .
   Google Scholar
• Schwarzenbach , G. , Gut , R. and Anderegg , G. 1954 . Komplexone XXV. Die polarographische untersuchung von austauschgleichgewichten. Neue daten der bildungkonstanten von metallkom‐plexen der athylendiamintetraessiggaure und der 1,2‐diaminocyclohexantetrasessigsaure . Helv. Chim. Acta , 37 : 937 – 957 .
   Web of Science ®Google Scholar
• Segoloni , G. , Canavese , C. , D'Amicone , M. , Rubino , G. F. , Scansetti , G. , Lamon , S. , Talarico , S. , Luda , E. and Vercellone , A. 1983 . Desferrioxamine and hemofiltration for aluminum removal in patients on regular dialysis treatment . Clin. Nephrol. , 20 : 105 – 108 .
   PubMed Web of Science ®Google Scholar
• Shannon , E. E. , Schmidtke , N. W. and Monaghan , B. A. 1978 . “ Activated sludge degradation of nitrilotriacetic acid (NTA)‐metal complexes ” . In Technol. Dev. Rep. EPS 4 (Canad. Environ. Prot. Serv.) EPS 4‐WP‐78–5
   Google Scholar
• Sherrard , D. J. , Walker , J. V. and Boykin , J. L. 1988 . Precipitation of dialysis dementia by deferoxamine treatment of aluminum‐related bone disease . Am. J. Kidney Dis. , 12 : 126 – 130 .
   PubMed Web of Science ®Google Scholar
• Shi , B. and Haug , A. 1990 . Aluminum uptake by neuroblastoma cells . J. Neurochem. , 55 : 551 – 558 .
   PubMed Web of Science ®Google Scholar
• Shore , D. and Wyatt , R. J. 1982 . Research design issues: Antialuminum drug studies in Alzheimer's disease . Clin. Neuropharmacol. , 5 : 337 – 343 .
   PubMed Web of Science ®Google Scholar
• Shore , D. , Sprague , S. M. , Mayor , G. H. , Moreno , E. C. , Apostoles , P. S. and Wyatt , R. J. 1985 . Aluminum‐fluoride complexes: Preclinical studies . J. Environ. Pathol. Toxicol. Oncol. , 6 : 9 – 13 .
   PubMed Web of Science ®Google Scholar
• Sideman , S. and Manor , D. 1982 . The dialysis dementia syndrome and aluminum intoxication . Nephron , 31 : 1 – 10 .
   PubMed Web of Science ®Google Scholar
• Siegel , N. and Haug , A. 1983 . Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies . Biochim. Biophys. Acta , 744 : 36 – 45 .
   PubMed Web of Science ®Google Scholar
• Sillen , L. G. and Martell , A. E. 1964 . Stability constants of metal‐ion complexes , Special Publ. 17 London : Chemical Society of London .
   Google Scholar
• Sillen , L. G. and Martell , A. E. 1971 . Stability constants of metal‐ion complexes, 1st Suppl. Part 1. Inorganic ligands. Part 2 , Organic including macromolecule ligands. Publ. 25 London : Chemical Society of London .
   Google Scholar
• Simon , P. , Ang , K. S. , Tanquerel , T. , Allain , P. and Mauras , Y. 1982 . Surcharge tissulaire en aluminium chez les hémodialysés. Test à la desferrioxamine . Nouv. Presse Méd. , 11 : 209
   PubMedGoogle Scholar
• Simon , P. , Ang , K. S. , Meyrier , A. , Allain , P. and Mauras , Y. 1983a . Desferrioxamine, ocular toxicity, and trace metals . Lancet , ii : 512 – 513 .
   Google Scholar
• Simon , P. , Ang. , K. S. , Cam , G. , Allain , P. and Maruas , Y. 1983b . Desferrioxamine, aluminium, and dialysis . Lancet , ii : 1489 – 1490 .
   Google Scholar
• Slanina , P. , Falkeborn , Y. , Freeh , W. and Cedergren , A. 1984 . Aluminium concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide . Food Chem. Toxicol. , 22 : 391 – 397 .
   PubMed Web of Science ®Google Scholar
• Slanina , P. , Freeh , W. , Bernhardson , A. , Cedergren , Å. and Mattsson , P. 1985 . Influence of dietary factors on aluminium absorption and retention in the brain and bone of rats . Acta Pharmacol. Toxicol. , 56 : 331 – 336 .
   PubMedGoogle Scholar
• Slanina , P. , Freeh , W. , Ekström , L.‐G. , Lööf , L. , Slorach , S. and Cedergren , A. 1986 . Dietary citric acid enhances absorption of aluminum in antacids . Clin. Chem. , 32 : 539 – 541 .
   PubMed Web of Science ®Google Scholar
• Smith , R. M. and Martell , A. E. , eds. 1989 . Critical Stability Constants, vol. 6, Second Supplement , vol. 6 , New York : Plenum Press .
   Google Scholar
• Song , Y.‐H. , Heins , S. , Mandelkow , E. and Mandelkow , E.‐M. 1991 . Aluminum fluoride, micro‐tubule stability, and kinesin rigor . J. Cell Sci. Suppl. , 14 : 147 – 150 .
   PubMedGoogle Scholar
• Spencer , H. and Lender , M. 1979 . Adverse effects of aluminum‐containing antacids on mineral metabolism . Gastroenterology , 76 : 603 – 606 .
   PubMed Web of Science ®Google Scholar
• Spencer , H. , Kramer , L. , Norris , C. and Wiatrowski , E. 1981 . Effect of aluminum hydroxide on plasma fluoride and fluoride excretion during a high fluoride intake in man . Toxicol. Appl. Pharmacol. , 58 : 140 – 144 .
   PubMed Web of Science ®Google Scholar
• Sternweis , P. C. and Gilman , A. G. 1982 . Aluminum: A requirement for activation of the regulatory component of adenylate cyclase by fluoride . Proc. Natl. Acad. Sci. USA , 79 : 4888 – 4891 .
   PubMed Web of Science ®Google Scholar
• Stevens , B. J. , Willis , G. L. , Humphrey , T. J. and Atkins , R. C. 1987 . Combined toxicity of aluminum and fluoride in the rat: Possible implications of hemodialysis . Trace Elem. Med. , 4 : 61 – 66 .
   Google Scholar
• Still , C. N. and Kelley , P. 1980 . On the incidence of primary degenerative dementia vs. water fluoride content in South Carolina . Neurotoxicology , 1 : 125 – 131 .
   Web of Science ®Google Scholar
• Stivelman , J. , Hakim , R. , Schulman , G. , Kelleher , S. and Lazarus , J. M. 1985 . Exacerbation of possible dialysis encephalopathy with deferoxamine . Am. J. Kidney Dis. , 6 : A21
   Web of Science ®Google Scholar
• Suhayda , C. G. and Haug , A. 1985 . Citrate chelation as a potential mechanism against aluminum toxicity in cells: the role of calmodulin . Can. J. Biochem. Cell Biol. , 63 : 1167 – 1175 .
   Google Scholar
• Sutton , D. A. and Marasas , L. W. 1959 . Urinary excretion of aluminium after administration in chelated forms . Experientia , 15 : 476 – 477 .
   PubMedGoogle Scholar
• Swartz , R. , Dombrouski , J. , Burnatowska‐Hledin , M. and Mayor , G. 1987 . Microcytic anemia in dialysis patients: Reversible marker of aluminum toxicity . Am. J. Kidney Dis. , 9 : 217 – 223 .
   PubMed Web of Science ®Google Scholar
• Tapparo , A. and Perazzolo , M. 1989 . N‐Octanol/water partition coefficients of the acetylacetonate and maltolate complexes of Al(III), Cr(III) and Fe(III) and of aluminum lactate . Int. J. Environ. Anal. Chem. , 36 : 13 – 16 .
   Web of Science ®Google Scholar
• Tikhonov , V. N. 1976 . Composition and stability of the complex of aluminum with aluminon . Chem. Abstr. , 85 : 522
   Google Scholar
• Ting , K.‐S. , Liang , Y.‐I. , Shi , J.‐M. , Chen , W.‐Z. , Gu , Z.‐P. and Jin , Y.‐F. 1965 . Detoxification of heavy metal poisonings by sodium dimercaptosuccinate . Zhonghua Yixue Zazhi (Chin. Med. J.) , 51 : 304 – 307 .
   Google Scholar
• Ding , G.‐S. and Liang , Y.‐Y. 1991 . Antidotal effects of dimercaptosuccinic acid . J. Appl Toxicol. , 11 : 7 – 14 .
   PubMed Web of Science ®Google Scholar
• Umeda , M. , Umimoto , K. , Tsurusaki , K. , Izumi , N. , Kishimoto , T. and Maekawa , M. 1988 . Effect of desferrioxamine infusion on red blood cell aluminum . Trans. Am. Soc. Artif. Intern. Organs , 34 : 297 – 299 .
   Google Scholar
• Van der Voet , G. B. , Van Ginkel , M. F. and de Wolff , F. A. 1989 . Intestinal absorption of aluminum in rats: Stimulation by citric acid and inhibition by dinitrophenol . Toxicol. Appl. Pharmacol. , 99 : 90 – 97 .
   PubMed Web of Science ®Google Scholar
• Van Ginkel , M. F. , Van der Voet , G. B. , Van Eijk , H. G. and de Wolff , F. A. 1990 . Aluminium binding to serum constituents: A role for transferrin and for citrate . J. Clin. Chem. Clin. Biochem. , 28 : 459 – 463 .
   PubMedGoogle Scholar
• Venturini , M. and Berthon , G. 1989 . Aluminum speciation studies in biological fluids. Part 2. Quantitative investigation of aluminum‐citrate complexes and appraisal of their potential significance in vivo . J. Inorganic Biochem. , 37 : 69 – 90 .
   PubMed Web of Science ®Google Scholar
• Venturini , M. , Berthon , G. and May , P. M. 1987 . Formation constant determinations for aluminium complexes with low‐molecular‐weight (L.M.W.) ligands and implications for relevant computer‐simulated distributions in blood plasma . Recl. Trav. Chim. Pays‐Bas , 106 : 406
   Google Scholar
• Verbeelen , D. , Smeyers‐Verbeke , J. , Van Hooff , I. , Van der Straeten , A. and De Roy , G. 1986 . The effect of desferrioxamine on concentration and distribution of aluminum in bone . Kidney Int. , 30 : 68 – 73 .
   PubMed Web of Science ®Google Scholar
• Verbeelen , D. , Smeyers‐Verbeke , J. , Van Hooff , I. and De Roy , G. 1988 . The effect of desferrioxamine on tissue aluminum concentration and bone histology in aluminum‐loaded rats with renal failure . J. Trace Elem. Electrol. Health Dis. , 2 : 67 – 72 .
   PubMed Web of Science ®Google Scholar
• Verbeelen , D. , Smeyers‐Verbeke , J. , Van Hooff , I. and De Roy , G. 1989 . Vitamin D, desferrioxamine and aluminum‐induced bone disease in uremic rats . Nephron , 53 : 54 – 60 .
   PubMed Web of Science ®Google Scholar
• Verpooten , G. A. , D'Haese , P. C. , Boelaert , J. R. , Becaus , I. , Lamberts , L. V. and DeBroe , M. E. 1992 . Pharmocokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients . Nephrol. Dial. Transplant. , 7 : 931 – 938 .
   PubMed Web of Science ®Google Scholar
• Volf , V. 1974 . Combined effect of DTPA and citrate on an intramuscular 239Pu deposit in rats . Health Phys. , 27 : 152 – 153 .
   PubMed Web of Science ®Google Scholar
• Walker , J. A. , Sherman , R. A. and Cody , R. P. 1990 . The effect of oral bases on enteral aluminum absorption . Arch. Intern. Med. , 150 : 2037 – 2039 .
   PubMedGoogle Scholar
• Wang , S. T. , Pizzolato , S. and Demshar , H. P. 1991 . Aluminum levels in normal human serum and urine as determined by Zeeman atomic absorption spectrometry . J. Anal. Toxicol. , 15 : 66 – 70 .
   PubMed Web of Science ®Google Scholar
• Weiss , L. G. , Danielson , B. G. , Fellström , B. and Wikström , B. 1989 . Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion . Nephron , 51 : 325 – 329 .
   PubMed Web of Science ®Google Scholar
• Weitl , F. L. and Raymond , K. N. 1981 . Lipophilic enterobactin analogues. Terminally N‐alkylated spermine/spermidine catecholcarboxamides . J. Organic Chem. , 46 : 5234 – 5237 .
   Web of Science ®Google Scholar
• Womack , F. C. and Colowick , S. P. 1979 . Proton‐dependent inhibition of yeast and brain hexo‐kinases by aluminum in ATP preparations . Proc. Natl. Acad. Sci. USA , 76 : 5080 – 5084 .
   PubMed Web of Science ®Google Scholar
• Yokel , R. A. 1992 . Assessment of aluminum (AD mobilization by 3‐hydroxypyridin‐4‐one chelators in the Al‐loaded rat: A microdialysis study . Toxicologist , 12 : 210
   Google Scholar
• Yokel , R. A. and Kostenbauder , H. B. 1987 . Assessment of potential aluminum chelators in an octanol/aqueous system and in the aluminum‐loaded rabbit . Toxicol. Appl. Pharmacol. , 91 : 281 – 294 .
   PubMed Web of Science ®Google Scholar
• Yokel , R. A. and McNamara , P. J. 1985 . Aluminum bioavailability and disposition in adult and immature rabbits . Toxicol. Appl. Pharmacol. , 77 : 344 – 352 .
   PubMed Web of Science ®Google Scholar
• Yokel , R. A. and McNamara , P. J. 1989 . Elevated aluminum persists in serum and tissues of rabbits after a six‐hour infusion . Toxicol. Appl. Pharmacol. , 98 : 133 – 138 .
   Google Scholar
• Yokel , R. A. , Lidums , V. and Ungerstedt , U. 1991a . Aluminum mobilization by desferrioxamine assessed by microdialysis of the blood, liver and brain . Toxicology , 66 : 313 – 324 .
   PubMed Web of Science ®Google Scholar
• Yokel , R. A. , Datta , A. K. and Jackson , E. G. 1991b . Evaluation of potential aluminum chelators in vitro by aluminum solubilization ability, aluminum mobilization from transferrin and the octanol/aqueous distribution of the chelators and their complexes with aluminum . J. Pharmacol. Exp.Ther. , 257 : 100 – 106 .
   PubMed Web of Science ®Google Scholar
• Yokel , R. A. , Sun , M.‐Z. , Wilson , J. G. and Kadaba , P. K. 1993 . Evaluation of the aluminum chelation potential of N,N'‐alkylene‐bis‐(substituted phenol)‐glycines [substituted EDDHA analogs] . Toxicologist , 13 : 304
   Google Scholar
• Yoshida , I. , Murase , I. , Motekaitis , R. J. and Martell , A. E. 1983 . New multidentate ligands. XXI. Synthesis, proton, and metal ion binding affinities of N,N’,N"‐tris[2‐(N‐hydroxycarbamoyl)ethyl]‐1,3,5‐benzenetricarboxamide (BAMTPH) . Can. J. Chem. , 61 : 2740 – 2744 .
   Web of Science ®Google Scholar
• Zatta , P. , Giordano , R. , Corain , B. , Favarato , M. and Bombi , G. G. 1987 . A neutral lipophilic compound of aluminum(III) as a cause of myocardial infarct in the rabbit . Toxicol. Lett. , 39 : 185 – 188 .
   PubMed Web of Science ®Google Scholar
• Zhang , G. and Taylor , G. J. 1989 . Kinetics of aluminum uptake by excised roots of aluminum‐tolerant and aluminum‐sensitive cultivars of Triticum aestivum L . Plant Physiol. , 91 : 1094 – 1099 .
   PubMed Web of Science ®Google Scholar